Zusammenfassung
Die akute Wundversorgung und die chronische Wundbehandlung gehören seit jeher zu den grundlegenden Kompetenzen des Chirurgen. Im Rahmen der zunehmenden Subspezialisierungen übernahm die Plastische Chirurgie diese Rolle, insbesondere für die große Gruppe der Wunden mit der semantisch unglücklichen Bezeichnung: „Problemwunden“. In die Gruppe dieser sog. Problemwunden (ca. 4 Millionen Patienten pro Jahr allein in Deutschland) fallen Wunden unterschiedlichster Genese, denen gemeinsam ist, dass sie mit gängigen Therapiemethoden nicht in üblicher Frist zur Abheilung gebracht werden können.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Weiterführende Literatur
Amann B et al (2009) Extremitätenerhalt durch autologe Knochenmarksstammzelltransplantation zur Induktion der Arteriogenese bei kritischer, nicht-revaskularisierbarer Extremitätenischämi. Chirurgie 134:298–304
Bader A, Machens HG (2010) Recombinant human EPO plays a pivotal role as a topical stem cell activator to reverse effects of damage to the skin in aging and trauma. Rejun Res 13:499
Bahlmann FH, De Groot K, Spandau JM, Landry AL, Hertel B, Duckert T, Boehm SM, Menne J, Haller H, Fliser D (2004) Erythropoietin regulates endothelial progenitor cells. Blood 103:921–926
Bahlmann FH et al (2004) Erythropoietin regulates endothelial progenitor cells. Blood 103:921–926
Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M (2008) Growth factors and cytokines in wound healing. Wound Rep Reg 16(5):585–601
Barrilleaux B et al (2006) Review: ex vivo engineering of living tissues with adult stem cells. Tissue Engineering 12:3007–3019
Brines M et al (2008) EPO-mediated tissue protection: reducing collateral damage from primary injury response. J Int Med 264:405–432
Chambers H et al (2007) Silver treatments for leg ulcers: a systematic review. Wound Rep Reg 15:165–173
Deutsche Diabetes-Union (2013) http://www.diabetesde.org/fileadmin/users/Patientenseite/PDFs_und_TEXTE/Infomaterial/Diabetes_Gesundheitsbericht_2013.pdf
Deutsche Gesellschaft für Phlebologie http://www.phlebology.de/home-v16/leitlinien-der-dgp-mainmenu/171-diagnostik-und-therapie-des-ulcus-cruris-venosum
Dougherty EJ (2008) An evidence based model comparing the cost-effectivesess of platelet-rich plasma gel to alternative therapies for patients with nonhealing diebetic foot ulcers. Adv Skin Wound Care 21(12):568–575
Driver VR, Autologel Diabetic Foot Ulcer Study Group et al (2006) A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatement of diabetic foot ulcers. Ostomy Wound Manage 52:68–70 (72, 74)
Egana JT, Danner S, Kremer M et al (2009) The use of glandular-derived stem cells to improve vascularization in scaffold-mediated dermal regeneration. Biometerials 30(30):5918–5926
Egana JT et al (2009) Use of human mesenchymal cells to improve vascularization in a mouse modl for scaffold-based dermal regeneration. Tissue Engineering 15:1191–1200
Eming SA et al (1998) Genetically modified human keratinocytes overexpressing PDGF-A enhance the performance of a composite skin graft. Human Gen Ther 9:529–539
Eppely BL et al (2004) Platelet quantifications and growth factor analysis from platelet-rich plasma : implications for wound healing. Plast Reconstr Surg 114:1502–1508
Eppely BL et al (2006) Platelet rich plasma: a review of biology and applications in plastic surgery. Plast Reconstr Surg 118:147e–159e
Falanga V et al (1992) Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers. J Dermatol Surg Oncol 18:604–606
Falanga V et al (2007) Autologous bone marrow-derived cultured menenchymal stm cells delivered in a fibrin spray accelerate healing in munine and hunam cutaneous wounds. Tissue Engineering 13:1299–1312
Falanga V (2000) Classifications for wound bed preparation and stimulation of chronic wounds. Wound Repair Regen 8:347–352
Falanga V (2005) Wound healing and its impairment in the diabetic foot. Lancet 366:1736–1743
Haroon ZA et al (2003) A novel role of EPO during fibrin-induced wound-healing response. Am J Pathol 163:993–1000
Hart CE (1993) Human keratinocytes are a major source of cutaneous platelet-derived growth factor. J Clin Invest 92:671–678
Haslik W et al (2007) First experience with the collagen-elastin matrix Matriderm as a dermal substitute in severe burn injuries of the hand. Burns 33:364–368
Hoffmann G (2008) Wassergefiltertes Infrarot A (wIRA) zur Verbesserung der Wundheilung bei akuten und chronischen Wunden [Water-filtered Infrared-A (wIRA) for the improvement of wound healing of acute and chronic wounds]. Wundmanagement 2:72–80
Horch RE, Augustin G, Germann G, Leffler M, Dragu A (2008) Ökonomische Aspekte in der chirurgischen Wundbehandlung. Chirurg 79:518–525
Kern S, Eichler H, Stoeve J, Klüter H, Bieback K (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24(5):1294–1301
King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21(9):1414–1431
Kujath P, Michelsen A (2008) Wunden – von der Physiologie zum Verband [Wounds – from physiology to wound dressing]. Dtsch Aerztebl Int 105(13):239–248
Lacci KM et al (2010) Platelet-rich plasma: support for its use in wound healing. Yale J Biol Med 83:1–9
De Laport L et al (2006) Design of modular non-viral gene therapy vectors. Biomaterials 27:947–954
Lorenz K et al (2008) Multilineage differentiation potential of human dermal skin-derived fibroblasts. Exp Dermatol 17:925–932
Lotze MT, Zeh HJ, Rubartelli A et al. (2007) The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev 220:60–81
Machens HG et al. (2006) EPO in Burns. EudraCT Number: 2006-002886-38, Protocol Number: 0506, ISRCT Number: ISRCTN95777824
Metcalfe AD et al (2007) Bioengineering skin using mechanisms of regeneration and repair. Biometherials 28:5100–5113
Millington JT, Norris TW (2000) Effective treatement strategies for diabetic foot wounds. J Fam Pract 49:40–48
Müller CK et al (2006) Angiogenetic gene-modified fibroblasts for induction of localized angiogenesis. J Surg Res 160:340–348
Mulligan RC (1993) The basic science of gene therapie. Science 260:926–932
Nikol S, Baumgartner I, Van Belle E (2008) Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol Ther 16(5)972–978
Occleston NL et al (2008) Prevention and reduction of scarring in the skin by transforming growth factor beta 3 (TGFβ-3): from laboratory discovery to clinical pharmaceutical. J Biomater Sci Polym Ed 19:1047–1063
Pelka RP (1997) Expertise zur Kostensituation bei chronischen Wunden. Kaufbeuren (NV)
Peterson TE et al (2007) EPO tecting the endothelium. Br J Pharmacol 150:823–825
Pierce GF et al (1995) Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence in PDGF in chronic nonhealing wounds. J Clin Invest 96:1336–1350
Pierce GF et al (1994) Tissue repair processes in healing chronic pressure ulcers treated with recombinant platelet-derived growth factor BB. Am J Pathol 145:1399–1410
Pietramaggiori G et al (2006) Freeze-dried platelet-rich plasma shows benificial healing properties in chronic wounds. Wound Repair Regen 14:573–380
Pietrzak WS et al (2005) Platelet rich plasma : biology and new technology. J Cranoiofac Surg 16:1043–1054
Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE, Wagber EH (1999) Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 22(3):382–387
Rennekampf HO et al (2010) Möglichkeiten und Grenzen der autologen Fetttransplantation – „Consensus Meeting“ der DGPRÄC in Hannover, September 2009. Handchir Mikrochir Plast Chir 42:137–142
Risau W (1997) Mechanisms of angiogenesis. Nature 386:671–674
Rockwell WB et al (1989) Keloids and Hyperthropic scars: a comprehensive Review. Plast Rec Surg 84:827–837
Rümenapf G et al (2009) Diagnostik und Therapie des DM Fußsyndroms aus gefäßchirurgischer Sicht. Orthopäde 38:1187–1194
S3-Leitlinie der Deutschen Gesellschaft für Phlebologie für die Diagnostik und Therapie des Ulcus cruris venosum, 2008
Sabthanam AV et al (2008) Activation of endothelial nitric oxide synthase is critical for EPO-induced mobilization of progenitor cells. Peptides 29:1451–1455
Schantz JT et al (2008) Allgemein-VisceralChirurgie up2date. Tissue Engineering 2(5):367–382
Shukla A et al (1998) Differential expression of proteins during healing of cutaneous wounds in experimental normal and chronic models. Biochem Biophys Res Commun 244:434–439
Spanholtz TA et al (2011) Vascular endothelial growth factor (VEGF(165)) plus basic fibroblast growth factor (bfgf) producing cells induce a mature and stable vascular network-a future therapy for ischemically challenged tissue. J Surg Res 171:329–338
Steed DL et al (1996) Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. J Am Coll Surg 183:61–64
Steinstraesser L et al (2007) Transient non-viral cutaneous gene delivery in burn wounds. J Gene Med 9:949–955
Supp DM, Boyce ST (2005) Engineered skin substitutes: practices and potentials. Clin Dermatol 23:403–412
Toma JG et al (2005) Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells 23:727–737
Ubbink DT et al (2008) Comparison of homecare costs of local wound care in surgical patients randomized between occlusive and gauze dressings. Surg Nurs, S 593–601
Vacanti JP, Langer R (2003) Tissue Engineering. Science 14:60
Vojtassak J et al (2006) Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot. Neuroendocrinol Lett 27:134–137
Wang GL et al (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA, S 5510–5514
Weltdiabetesverband (2003) Diabetes Atlas. https://www.idf.org/sites/default/files/IDF_Diabetes_Atlas_2ndEd.pdf
Wilhelmi BJ, Neumeister M (2006) Pressure ulcers: Surgical treatment and principles. Emedicine.com
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Machens, HG., Günter, C.I. (2017). Innovative Therapien der Wundheilung. In: Berger, A., Hierner, R., Pallua, N. (eds) Plastische Chirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-48849-2_11
Download citation
DOI: https://doi.org/10.1007/978-3-662-48849-2_11
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-48848-5
Online ISBN: 978-3-662-48849-2
eBook Packages: Medicine (German Language)